Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04667559 · ClinicalTrials.gov registry record
A Study to Evaluate the Conformis iTotal Identity Knee Replacement System
A clinical trial, sponsored by Restor3D.
- Terminated
- Registry status
- 22
- Enrollment target
NCT04667559: Clinical Trial study, sponsored by Restor3D.
NCT04667559 is a clinical trial that was terminated before completion, run by Restor3D. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04667559 was terminated before completion, sponsored by Restor3D.
- TERMINATED
- Registry status
- 22 participants
- Enrollment target
Study Summary
This is a prospective multicenter study located in the United States. Subjects will be implanted with an iTotal Identity Knee Replacement System and followed for 10 years post implantation.
Primary Outcome
Measured by 2011 Knee Society Clinical Rating Score (objective knee score 0-125, function score 0-100, satisfaction score 0-40, expectation score 0-15 with higher scores meaning better outcome)
Interventions
- DEVICE Conformis iTotal Identity Knee Replacement System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-10-12 |
| Est. Completion | 2022-12-14 |
Why NCT04667559 stopped before completion
NCT04667559 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Conformis iTotal Identity Knee Replacement System is the first listed.
NCT04667559 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04667559 about?
NCT04667559 is a clinical study titled "A Study to Evaluate the Conformis iTotal Identity Knee Replacement System". This is a prospective multicenter study located in the United States. Subjects will be implanted with an iTotal Identity Knee Replacement System and followed for 10 years post implantation.
What is the current status of trial NCT04667559?
This trial is currently terminated. The enrollment target is 22 participants. The study started on 2020-10-12. Estimated completion is 2022-12-14.
What interventions are being tested in trial NCT04667559?
The interventions under investigation include: Conformis iTotal Identity Knee Replacement System (DEVICE).
Who is sponsoring clinical trial NCT04667559?
This trial is sponsored by Restor3D, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI